期刊文献+

血清胱抑素c在早期慢性肾衰竭诊断中的价值 被引量:9

下载PDF
导出
摘要 目的:探讨慢性肾衰竭患者及慢性肾衰竭临床各期患者血清胱抑素c(cystatin c,cys c)和血清肌酐(Scr)的异常情况,评价cys c在早期诊断慢性肾衰竭患者中的应用价值。方法:根据肌酐清除率(Ccr)将59例健康体检者作为正常对照组,200例Ccr<80mL/min的患者作为慢性肾衰竭组,比较正常对照组与慢性肾衰竭患者及慢性肾衰竭临床各期患者cys c和Scr的异常情况,其中,慢性肾衰竭组患者根据Ccr分为肾功能代偿期组、肾功能失代偿期组、肾功能衰竭期组、尿毒症期组,测定各组的cys c和Scr含量。结果:正常对照组和慢性肾衰竭组之间的cys c和Scr差异均有显著性(P<0.01)。而在各亚组的比较中,cys c和Scr浓度随着肾功能的损害程度的增加而上升,正常对照组和肾功能代偿期组的cys c比较差异有显著性,而Scr比较差异无显著性。结论:cys c比Scr对早期诊断慢性肾衰竭更有意义。
作者 刘翠兰
出处 《现代医药卫生》 2011年第15期2297-2298,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献7

  • 1Grubb A, Simonsen O, Stfeit G, et al.Serum concentration of cystat- inC, factorD and β2 mincroglbulin as a measure of glomerular filtra- tion rate[J].Acta Meed Scand, 1985,218:499.
  • 2王鸿利.实验诊断学[M].北京:人民卫生出版社,2004.240,241.
  • 3Keevil GB ,Kilpatrick ES,Nichols SP,et al.Niologi eal variation of cystain :implication for the assessment of glomerular filtration rate [J]. Clin Chem, 1998,44(7):1535.
  • 4Mussap M, Ruzzante N, Varagnolo M, et al.Quantitative automated partical-enhanced immunonephelometric assay for the routinary mea- surement of human cystatin[J].Clin Lab Med, 1998,36(11): 859.
  • 5Tian S, Kusano E, Ohara T, et al.Cystatin C measurement and its practical use in patients with various renal diseases[J].Clin Nephrol, 1997,48(2) : 104.
  • 6李海霞,吴红花,徐国宾,郭晓蕙,夏铁安.血清半胱氨酸蛋白酶抑制剂C与肌酐在评价糖尿病患者肾小球滤过功能中的比较研究[J].中华检验医学杂志,2005,28(6):602-605. 被引量:107
  • 7刘航,陈香美.胱蛋白酶抑制剂C与肾脏[J].中国实验诊断学,2001,5(4):151-153. 被引量:24

二级参考文献25

  • 1[1]Fanos V, Mussap M, Plebani M, et al. Cystatin C in pediatric: Present situation and prospect[J]. Minerva Pediatr, 1999,51(5): 167.
  • 2[2]Randers E, Erlandsen EJ . Serum cystatin C as an endogenous marker of the reanl function-a review[J]. Clin Chem Lab Med, 1999, 37(4):389.
  • 3[3]Keevil BG, Kilpatrick ES, Nichols SP, et al. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate[J]. Clin Chem, 1998, 44(7):1535.
  • 4[4]Bokenkamp A, Domanertzki M, Zinck R, et al. Reference values for cystatin C serum concentration in children[J]. Padiatr Nephrol, 1998,12(2): 125.
  • 5[5]Tian S, Kusano E, Ohara T, et al. Cystatin C measurement and its practical use in patients with various renal diseases[J]. Clin Nephrol,1997, 48(2): 104.
  • 6[6]Fliser D, Ritz E. Serum cystatin C concertration as a marker of renal dysfunction in the elderly[J]. Am J Kidney Dis ,2001, 37(1) :79.
  • 7[7]Mojimintyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus[J]. Scand J Clin Lab Invest ,2000, 60(6) :483.
  • 8[8]Chantrel F, Agin A, Offner M et al. Comparison of cystatin C versus creatinine for detection of mild renal failure[J]. Oin Nephrol ,2000,54(5): 374.
  • 9[9]Hamoinen A, Ylinen E, Ala-Houhala M, et al. Reference intervals for cystatin C in pre-and full-temm infants and children [J ]. Padiatr Nephrol, 2000, 15(1-2): 105.
  • 10[10]Randers E, Erlandsen EJ, Pedersen OL, et al. Serum cystatin C as an endogenous paramenter of the renal function in patients with norral to moderately impairde kidney function[J]. Clin Nephrol,2000, 54(3):203.

共引文献158

同被引文献53

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部